Biotech ETF has held up well, and looks primed for bullish continuation. My guess is biotech brands are ramping up. They patent the altered viruses, and then sell you vaccines in a Faustian and Hegelian mix up.
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。